View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Uncategorised
April 29, 2020

Abbott announces immediate availability of Covid-19 test across Europe

By Chloe Kent

Abbott has announced the receipt of a CE mark for its lab-based Covid-19 antibody test, thousands of which have already started shipping across Europe.

The SARS-CoV-2 IgG test identifies Covid-19 IgG antibody, a protein the body produces in the late stages of infection, and which can linger for months or even years after recovery. The test was able to demonstrate both sensitivity and specificity of over 99% 14 days or more after symptoms start during initial testing.

The test will initially run on Abbott’s Architect i1000SR and i2000SE lab instruments and will expand to the Alinity i system.

Abbott plans to expand its Covid-19 antibody testing to IgM antibodies in the near future.

Abbott Northern Europe managing director of diagnostics Mike Clayton said: “We are proud to be able to provide our antibody tests immediately as they will help understand who has had the virus, leading to greater confidence as we get back to living life. We are collaborating with the NHS, public health bodies and private laboratories across the UK to enable this test to be used here.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network